Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor 2

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × alpha-Synuclein × Clear all
NCT03815084 2019-01-30

A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
100 enrolled
Other solid neoplasm

Solid Tumor

NCT03815630 2019-01-30

DC-CIK

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
100 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡